Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > RDW speculation.

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Dec 20, 2022 11:05am

224 Views

Post# 35182139

RE:RE:RE:RE:RE:RE:RDW speculation.

ScienceFirst wrote: Plantrader ... It's already been discussed. Announcing application for BTD is not material. So at the discretion of the company. But the final decision of the FDA is material though.

I recently documented different examples, from TLT and abroad.

The only thing that is sure is that TLT has reached the milestone requested by the FDA to apply; 450-days of p#25. And TLT will apply when they have all the info. (scans, documents from urologists, etc ...).

SF, thanks for that info. Now I don't have to wonder why they're silent. This board was such a mess for a while, it's tough to go back to refresh or find older info/posts.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages